This is a multicenter, randomized clinical trial evaluating outcomes of transcatheter edge-to-edge tricuspid valve repair compared to optimized medical management in 350 patients with severe tricuspid regurgitation.

Analysis of post-procedure outcomes and mid-term follow-up of TAVI vs. SVA in a U.S. healthcare insurance database for patients with pure aortic insufficiency.

This retrospective American study evaluates short- and mid-term outcomes in a cohort of 56,331 patients with severe aortic stenosis and bicuspid aortic valve (BAV) undergoing conventional aortic valve replacement (AVR) or transcatheter implantation (TAVI).

Review article examining the boundaries of TAVI indication in favor of aortic valve replacement based on currently available evidence.

A comparative review of different non-transfemoral alternative access options for TAVI, with the objective of providing updated information on the latest techniques, outcomes, and advances in the field.

This nationwide retrospective study from Taiwan evaluates outcomes of biological versus mechanical mitral valve replacement in 1,576 patients.

This retrospective, multicenter study utilizes latent class analysis on 2321 patients undergoing surgery for primary mitral valve disease, aiming to identify phenotypes with distinct long-term prognoses.

This study evaluates the five-year clinical and echocardiographic outcomes of patients with severe degenerative mitral regurgitation (MR) treated with transapical neochord implantation using the NeoChord DS 1000® device.

Results from a Japanese and a Swedish center, sourced from the international TAVI Registry, comparing 1-year post-TAVI survival and morbidity among patients with mild residual paravalvular leakage and those with no residual/trivial leakage post-implantation.

This commentary presents a sub-analysis of the CAMRA CardioLink-2 clinical trial, which investigates risk factors associated with elevated mean mitral gradients following mitral repair.